Cintas delivered impressive fiscal 2025 third-quarter results with earnings and revenue exceeding market expectations.
Q3 2025 results showed a 9% YoY sales decline, 330 bps gross margin hit, and a 32% drop in net income, raising concerns about ...
Analysts expect the Rochester, New York-based company to report quarterly earnings at $1.48 per share, up from $1.38 per ...
The Motley Fool on MSN7d
General Mills Q3 Revenue Falls 5%
Q3 revenue stood at $4.8 billion, down from $5.1 billion, marking a 5% decrease. Adjusted EPS fell by 15% to $1.00, driven ...
Q3 2025 Management View CEO Todd Schneider highlighted that total revenue grew 8.4% to $2.61 billion in Q3, with an organic growth rate of 7.9%. Uniform Rental and Facility Services achieved 7% growth ...
Q3 2025 Results Conference Call March 27, 2025 5:00 PM ETCompany ParticipantsWendy Watson - VP of IRJeff Stutz - ...
Equities research analysts at HC Wainwright issued their Q3 2025 earnings estimates for Context Therapeutics in a research report issued on Friday, March 21st. HC Wainwright analyst E. Bodnar ...
Analysts at Zacks Research decreased their Q3 2025 earnings estimates for Avanos Medical in a research note issued to ...